We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Live Images of Growing Tumors Reveals Cancer’s Hidden Mechanisms

By LabMedica International staff writers
Posted on 25 Sep 2013
A group of researchers has developed a novel new optical imaging tool that enables them to look deep within tumors and reveal their inner processes, helping them to understand the slight, frequently concealed, changes to DNA, cells, proteins, and tissue that alter the body’s healthy biochemistry and cause disease. More...


In research that will be presented at Frontiers in Optics (FiO), the Optical Society’s (OSA) annual meeting, to be held October 6–10, 2013, in Orlando (FL, USA), Dr. Dai Fukumura and his colleagues will present new optical imaging technology designed to track the movement of molecules, cells, and fluids within tumors; study abnormalities in the blood vessel network inside them; and observe how the tumors were affected by treatments.

These techniques, created by Dr. Fukumura and his long-term collaborators at Massachusetts General Hospital (MGH; Boston, MA, USA) and Harvard Medical School (Boston, MA, USA), combine two different high-tech optical imaging methods that were personalized for the research purposed. One approach is called multiphoton laser-scanning microscopy (MPLSM), which is a sophisticated fluorescence imaging technology that is now commercially available at the high end of the microscope market. The other is called optical frequency domain imaging (OFDI), which images tissues by their light scattering characteristics. OFDI is gaining acceptance in the optical imaging field but has not yet to become commercially available, according to Dr. Fukumura. “MPLSM overcomes many of the limitations from which conventional microscopy and confocal microscopy suffer, and OFDI provides robust large volume imaging data,” Dr. Fukumura said.

At FiO 2013, Dr. Fukumura will describe how his unique technique can image tumors completely, and show detailed pictures of live tumors—images that he and colleagues call “astonishing.” He noted that while the new integrated tool would be too costly to be used for regular diagnostic purposes, it has the potential to help scientists better figure out the obscure mechanisms of human cancer and aid in drug discovery for cancer therapy. “These optical imaging approaches can provide unprecedented insights in the biology and mechanisms of cancer,” he concluded.


Related Links:
Massachusetts General Hospital
Harvard Medical School


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.